Surprisingly, the SURMOUNT-5 trial found that fewer people discontinued tirzepatide due to side effects (2.7%) compared to semaglutide (5.6%)
Side effects can include nausea, vomiting, low blood sugar, and kidney injury, so discuss safer access and alternatives with your doctor
Sudden one-eye vision loss requires emergency room evaluation for possible NAION
And the best part
Bases for the FDAs Decision The FDA is required to maintain an up-to-date list of drugs that are determined by [the FDA] to be in shortage in the United States[vii] with a shortage being a period of time when the demand or projected demand for the drug within the United Sates exceeds the supply of the drug.[viii] To reach its decision, the FDA noted its consideration of information from numerous stakeholders, including individuals, telehealth companies, pharmacy compounders, associations representing pharmacy compounders, outsourcing facilities, and Novo Nordisk, the manufacturer of Wegovy and Ozempic
3 months: 7% of body weight lost 6 months: 12% of body weight lost Remember, these numbers are averages
